Immunovant Up Over 17%, On Track for Largest Percent Increase Since September 2023 -- Data Talk

Dow Jones
2025/10/31

Immunovant Inc. $(IMVT)$ is currently at $25.40, up $3.76 or 17.34%

 

--Would be highest close since Dec. 26, 2024, when it closed at $25.73

--On pace for largest percent increase since Sept. 26, 2023, when it rose 97.04%

--Currently up four of the past five days

--Up 57.6% month-to-date; on pace for best month since Sept. 2023, when it rose 69.04%

--Up 2.56% year-to-date; on pace for best year since 2023, when it rose 137.35%

--Down 51.8% from its all-time closing high of $52.71 on Nov. 17, 2020

--Down 13.17% from 52 weeks ago (Oct. 31, 2024), when it closed at $29.26

--Down 19.14% from its 52-week closing high of $31.42 on Nov. 6, 2024

--Up 90.87% from its 52-week closing low of $13.31 on April 8, 2025

--Traded as high as $26.17; highest intraday level since Dec. 26, 2024, when it hit $26.46

--Up 20.88% at today's intraday high; largest intraday percent increase since Sept. 26, 2023, when it rose as much as 105.72%

 

All data as of 2:19:40 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 30, 2025 14:22 ET (18:22 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10